This bill requires drug manufacturers to provide the Department of Health and Human Services with aggregate data related to product samples of drugs, devices, biologic products, and medical supplies given to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2019-05-21 | Committee | Subcommittee Hearings Held. | House committee actions |
| 2019-04-04 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2019-04-03 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2019-04-03 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2019-04-03 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2019-04-03 | IntroReferral | Introduced in House | Library of Congress |